An amphiphilic, PK/PBAN analog is a selective pheromonotropic antagonist that penetrates the cuticle of a heliothine insect.
A linear pyrokinin (PK)/pheromone biosynthesis activating neuropeptide (PBAN) antagonist lead (RYF[dF]PRLa) was structurally modified to impart amphiphilic properties to enhance its ability to transmigrate the hydrophobic cuticle of noctuid moth species and yet retain aqueous solubility in the hemolymph to reach target PK/PBAN receptors within the internal insect environment. The resulting novel PK/PBAN analog, Hex-Suc-A[dF]PRLa (PPK-AA), was synthesized and evaluated as an antagonist in a pheromonotropic assay in Heliothis peltigera against 4 natural PK/PBAN peptide elicitors (PBAN; pheromonotropin, PT; myotropin, MT; leucopyrokinin, LPK) and in a melanotropic assay in Spodoptera littoralis against 3 natural PK/PBAN peptide elicitors (PBAN, PT, LPK). The analog proved to be a potent and efficacious inhibitor of sex pheromone biosynthesis elicited by PBAN (84% at 100 pmol) and PT (54% at 100 pmol), but not by MT and LPK. PPK-AA is a selective pure antagonist (i.e., does not exhibit any agonistic activity) as it failed to inhibit melanization elicited by any of the natural PK/PBAN peptides. The analog was shown to transmigrate isolated cuticle dissected from adult female Heliothis virescens moths to a high extent of 25-30% (130-150 pmol), representing physiologically significant quantities. PPK-AA represents a significant addition to the arsenal of tools available to arthropod endocrinologists studying the endogenous mechanisms of PK/PBAN regulated processes, and a prototype for the development of environmentally friendly pest management agents capable of disrupting the critical process of reproduction.
Nachman
Ronald J
RJ
Areawide Pest Management Research, Southern Plains Agricultural Research Center, U.S. Department of Agriculture, College Station, TX 77845, USA. nachman@tamu.edu
Teal
Peter E A
PE
Aziz
Orna Ben
OB
Davidovitch
Michael
M
Zubrzak
Pawel
P
Altstein
Miriam
M
D000818:Animals; D001681:Biological Assay; D005260:Female; D052717:Melanotrophs / Q000187:drug effects; D009036:Moths / Q000187:drug effects*; D009479:Neuropeptides / Q000138:chemical synthesis / Q000494:pharmacology*; D009842:Oligopeptides; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D012724:Sex Attractants / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D013501:Surface-Active Agents / Q000138:chemical synthesis / Q000494:pharmacology*
D009479:Neuropeptides; D009842:Oligopeptides; D012724:Sex Attractants; D013501:Surface-Active Agents; C079229:pyrokinin; C049557:leucopyrokinin; D011761:Pyrrolidonecarboxylic Acid